Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Citius Pharmaceuticals Inc (NQ: CTXR ) 0.5699 +0.0218 (+3.98%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,641,581 Open 0.5700 Bid (Size) 0.5600 (26) Ask (Size) 0.5699 (1) Prev. Close 0.5481 Today's Range 0.5371 - 0.5769 52wk Range 0.4800 - 1.070 Shares Outstanding 145,979,429 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CTXR Stock Earnings: Citius Pharma Meets EPS for Q3 2024 August 12, 2024 CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the third quarter of 2024. Via InvestorPlace Penny Stock Citius Pharmaceuticals Secures Its First FDA Approval For Skin Cancer Drug A Year After FDA Rejection August 08, 2024 Citius Pharmaceuticals receives FDA approval for Lymphir, the first therapy targeting the IL-2 receptor in relapsed or refractory cutaneous T-cell lymphoma. U.S. market launch planned within five... Via Benzinga Exposures Product Safety Performance YTD -29.53% -29.53% 1 Month -0.59% -0.59% 3 Month -10.60% -10.60% 6 Month -28.94% -28.94% 1 Year -18.33% -18.33% More News Read More Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology August 06, 2024 Via News Direct Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products July 30, 2024 Via News Direct This Pharma Company Is Preparing To Launch Its Lead Candidate July 25, 2024 Via News Direct Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL) July 18, 2024 Via Newsfile Exposures Product Safety Analysts Hunt for Undervalued Biotech Stocks July 17, 2024 Via Newsfile Topics Economy Initial Public Offering Exposures Interest Rates Securities Market Citius Pharmaceuticals (CTXR) Eyes Breakthrough with Late-Stage Drug Pipeline Poised for Regulatory Approval July 17, 2024 Via AB Newswire Bloodstream Infections - From Threats to Solutions July 11, 2024 Via Newsfile Topics Death Exposures Death Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024 July 11, 2024 Via AB Newswire Exposures Product Safety Biopharma Stocks Transformative Innovation for the Future of Health July 11, 2024 Via Newsfile Topics Artificial Intelligence Exposures Artificial Intelligence Citius Pharma's 'Antibiotic Lock' Effective In Patients With Catheter-Associated Bloodstream Infections May 21, 2024 Via Benzinga Yogi Tea Recalls: Yogi Brand Recalls 900,000 Tea Bags for Pesticide Residue May 21, 2024 Via InvestorPlace Topics Product Recall Exposures Legal Product Safety VFS Stock Alert: VinFast Plunges on NHTSA Probe May 21, 2024 Via InvestorPlace Why Is Citius Pharmaceuticals (CTXR) Stock Up 11% Today? May 21, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 21, 2024 Via Benzinga Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Featured in Coverage of the EF Hutton Annual Global Conference May 16, 2024 Via Investor Brand Network Exposures Product Safety CTXR Stock Earnings: Citius Pharma Meets EPS for Q2 2024 May 14, 2024 Via InvestorPlace Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment April 18, 2024 Via News Direct Topics Death Exposures Death 12 Health Care Stocks Moving In Thursday's Pre-Market Session April 18, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 18, 2024 Via InvestorPlace Sidoti Events, LLC’s Virtual November Micro-Cap Conference November 14, 2023 Via ACCESSWIRE 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 24, 2023 Via Benzinga Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session July 31, 2023 Via Benzinga Why Citius Pharmaceuticals Stock Is Plunging Today? July 31, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
